CP1 cannpal animal therapeutics limited
Add to My Watchlist 0.00% ! 17.0¢

News: CP1 Cannpal Animal Therapeutics Says Co Receives Ethics Approvals For Phase 1B Study In Dogs

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    02/08/18
    09:05
    Post #: 34682256

    Aug 2 (Reuters) - CannPal Animal Therapeutics Ltd (CP1) :

    • RECEIVES ETHICS APPROVALS FOR PHASE 1B STUDY IN DOGS
    • CANNPAL ANIMAL THERAPEUTICS - RECEIVED ETHICS APPROVALS TO ADVANCE DEVELOPMENT OF ITS LEAD DRUG CANDIDATE, CPAT-01, A PAIN CONTROL IN DOGS
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.